Abstract
Polycythaemia vera (PV) is an haematological neoplasm that frequently presents neurological symptoms. However, chorea is a rare complication of this disease, occurring in less than 5% of the patients. Cognitive impairment related to PV unbalanced is also a rare complication, and it can improve with proper treatment. We present a 96-year-old-man with acute-onset hemichorea and frontal lobe syndrome with no vascular pathology in the basal ganglia or frontal region. A clear relationship was observed between the onset of involuntary movements and the cognitive impairment and worsening of haematological parameters in the patient. After causal and symptomatic treatment, the patient’s clinical status improved. In the elderly, PV must be considered as a cause of acute chorea and sudden cognitive impairment, as early diagnosis leads to effective treatment and prevention of complications.
Keywords: movement disorders (other than Parkinsons), memory disorders, haematology (incl blood transfusion)
Background
Chorea is a hyperkinetic movement disorder occurring mostly due to infectious, vascular, hereditary, drug-induced or metabolic causes.1
Polycythaemia vera (PV) is a myeloproliferative neoplasm characterised by elevated haemoglobin (Hb) and bone marrow panmyelosis.2
Neurological manifestations of PV such as headache, vertigo and transient ischaemic attacks are frequent (50%–78%), but chorea is rare and infrequently reported as a complication of the disease (1%–5%).3
Polycythaemic chorea manifest itself after the age of 50, and most cases have an acute onset or present as a sudden aggravation of a pre-existing symptom. The choreic syndrome is usually generalised with predominantly faciobrachial muscle involvement.4 5
The frontal lobe syndrome in PV has been described once, and cognitive impairment with partial reversibility on lowering of the haematocrit (Ht) has been reported before.6 7
Because of these uncommon symptoms, it is needed to investigate the presence of PV as a potentially treatable cause in elderly patients with new-onset movement disorder.
Our aim is to present a patient with hemichorea and frontal lobe syndrome as the main manifestation of unbalanced PV.
Case presentation
A 96-year-old man presented to our emergency room with sudden-onset left-sided involuntary movements involving the upper limb and face that had developed 4 days earlier. Concomitantly, he had demonstrated progressive behavioural change which family members described as social disinhibited behaviour that included inappropriate verbal comments and unrestrained laugh.
His medical history included hypertension, atrial fibrillation (treated with a direct anticoagulant agent, apixaban) and chronic lower limb ischaemia. He also has a PV that was treated with hydroxyurea for a long time, but the haematologist had decided to retired a month ago.
He was not being treated with chorea-induced drugs such antiparkinsonian drugs, antipsychotics, amphetamines or tricyclic antidepressants.
There was no family history of movement disorders, dementia or psychiatric illness.
His physical showed choreic movements involving orofacial and brachial muscles. These movements were random and fleeting from one part to the body to another, causing difficulty in day-a-day activities. Neuropsychological testing showed mild cognitive impairment, with predominantly extensive frontal symptomatology (tendency to imitate, disinhibition…).
There was no clubbing, splenomegaly or evidence of peripheral venous thrombosis.
Cardiovascular examination was unremarkable.
Investigations
On hospital admission, laboratory testing showed elevated Hb (15.5 gr/dl, reference 12–15), higher Ht than previous (46%, reference 35–45) and elevated mean corpuscular volume (MCV). In retrospect, Hb, MCV and Ht values had been rising since 1 month before presentation (figure 1).
Figure 1.

Haematocrit levels.
Other laboratory tests were normal, including coagulation indicators.
The sudden appearance of left-sided hemichorea in a patient with a former Atrial fibrillation (AF) raised the suspicion of a vascular event in the basal ganglia region, however a CT of the brain was normal (figure 2).
Figure 2.

CT of the brain.
The patient had a pacemaker that was not compatible with MRI, so it could not be performed.
The absence of vascular stenosis, both in supra-aortic trunks and in the polygon of Willis, was also confirmed by a neurosonological study that was normal.
Differential diagnosis
Differential diagnosis of chorea is shown in table 1.
Table 1.
Differential diagnosis of chorea
| Type of chorea | Characteristics |
Inherited/degenerative choreas:
|
Onset typically >18 years Gradual onset |
Autoimmune chorea:
|
Onset typically >18 years Acute onset |
Other choreas:
|
Onset typically >18 years Acute onset Variable age of onset, acute onset Onset typically > 60 years Acute onset |
Treatment
As the violence of involuntary movements required symptomatic treatment during follow-up, at first, haloperidol was initiated which was not effective. Then it was decided to start clonazepam 2 mg every 8 hours which was not effective either. The improvement had to do with the establishment of hydroxyurea as previously.
Outcome and follow-up
Following the PV treatment, a decrease in the severity of involuntary movements was observed. Unfortunately, because of the symptomatic agents his level of consciousness decreased, and he suffered aspiration pneumonia.
Discussion
Although neurological manifestations of PV, such as headache, dizziness, paraesthesias or stroke, are frequent, chorea is a rare symptom with a prevalence of 1%–5%.3 There are some case reports that described reversible cognitive impairment in PV, and in one of them the authors reported a frontal lobe syndrome similar to our patient.6 7
Polycythaemic chorea manifests itself predominantly after the age of 50, making PV the first disorder to be considered in cases of senile chorea. Most cases have an acute onset, and the syndrome is usually generalised with predominantly orofacial and brachial involvement.4
Although the chorea caused by PV is due to metabolic cause, in most of the cases described in the literature, its presentation is unilateral, so in this case, the decompensation of the patient’s base disease, the improvement with normalisation of the Ht levels and the absence of vascular alterations would justify the clinical presentation in this patient.3 4
The majority of the choreic or cognitive manifestations appear after the exacerbation of haematological parameters. This supports the theory that hyperviscosity is the determining factor in the pathophysiology. In the case of chorea, neostriatal hyperviscosity in the brain leads to venous stasis, low brain blood flow and impaired oxygen and glucose metabolism, causing movement disorder. It is possible that the pathophysiology of frontal lobe syndrome is based on the same principle as polycythaemic chorea.8
Proper treatment of PV and restoration of Hb and Ht levels lead to a reversibility of choreic and cognitive symptoms. In the treatment, venesection appears to be the initial method of choice, but bone marrow suppressor agents should also be given.
In the present case, PV was diagnosed and successfully managed by hydroxyurea; it illustrated the need to investigate the presence of polycythaemia as a potentially treatable cause in elderly patients with new-onset movement disorder.
Learning points.
Chorea is an hyperkinetic movement disorder occurring mostly due to infectious, vascular, hereditary, drug-induced or metabolic causes.
Neurological symptoms are frequent in some haematological diseases as polycythaemia vera (PV).
Polycythaemic chorea manifests itself predominantly after the age of 50, making PV the first disorder to be considered in cases of senile chorea.
Footnotes
Contributors: CG-C: conception or design of the work, data collection, data analysis and interpretation, drafting the article. JF-D: critical revision of the article. VM: final approval of the version to be published.
Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests: None declared.
Patient consent: Obtained.
Provenance and peer review: Not commissioned; externally peer reviewed.
References
- 1. Shannon MK. Chorea:differential diagnosis, evaluation and treatment: American Academy of Neurology San Francisco; 56 th Annual Meeting. [Google Scholar]
- 2. Thiele J, Hm K, Genmig V, et al. : Swerrdlow SH, Campo E, Harris NL, Jaffe ES, Pilori SA, WHO Classification of tumours of haematopoietic tissues. 4th edn Lyon: International Agency for reseach on Cancer, 2008:40–3. [Google Scholar]
- 3. Janavs JL, Aminoff MJ. Dystonia and chorea in acquired systemic disorders. J Neurol Neurosurg Psychiatry 1998;65:436–45. 10.1136/jnnp.65.4.436 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Midi I, Dib H, Köseoglu M, et al. Hemichorea associated with polycythaemia vera. Neurol Sci 2006;27:439–41. 10.1007/s10072-006-0727-3 [DOI] [PubMed] [Google Scholar]
- 5. Bhargava R, Dass J, Singh S, et al. Hemichorea, a rare presenting feature of polycythemia vera. Neurol India 2013;61:86–7. 10.4103/0028-3886.108027 [DOI] [PubMed] [Google Scholar]
- 6. Severs M, Boelens HM, Diraoui SB, et al. Chorea and a frontal lobe syndrome: a rare neurological presentation of polycythemia vera; a case report. J Am Geriatr Soc 2012;60:589–90. 10.1111/j.1532-5415.2011.03850.x [DOI] [PubMed] [Google Scholar]
- 7. Di Pollina L, Mulligan R, Juillerat Van der Linden A, et al. Cognitive impairment in polycythemia vera: partial reversibility upon lowering of the hematocrit. Eur Neurol 2000;44:57–9. 10.1159/000008194 [DOI] [PubMed] [Google Scholar]
- 8. Kwaan HC, Wang J. Hyperviscosity in polycythemia vera and other red cell abnormalities. Semin Thromb Hemost 2003;29:451–8. 10.1055/s-2003-44552 [DOI] [PubMed] [Google Scholar]
